BMJ29d
Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases
5 Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK 6 Centre for Integrated Genomic Medical Research, The University of ...
rmdopen.bmj9d
Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
Objective As rheumatoid factor (RF) and anticitrullinated protein antibodies (ACPAs) are not routinely tested in idiopathic inflammatory myositis (IIM), little is known about their prevalence and ...
BMJ27d
Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies
Objectives Myositis is a heterogeneous family of diseases including dermatomyositis (DM), immune-mediated necrotising myopathy (IMNM), antisynthetase syndrome (AS) and inclusion body myositis (IBM).
Frontiers28d
Anti-synthetase syndrome with anti-PL-7 antibody positive in a child: a case report and literature review
Deparment of Pediatric Nephrology, Rheumatology and Immunity, The Affiliated Hospital Of Qingdao University, Qingdao, China Background: Anti-synthetase syndrome (ASS) is a rare autoimmune myopathy and ...
verywellhealth21d
5 Changes You May Notice in Your Body After Taking Testosterone Boosters
Testosterone boosters are either prescription medications or dietary supplements intended to raise your testosterone levels. The supplements are marketed to males and females as a "natural" way to ...
BMJ15d
Split-hand and split-limb phenomena in amyotrophic lateral sclerosis: pathophysiology, electrophysiology and clinical manifestations
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting the upper and lower motor neurons. A key clinical feature of ALS is the absence of accurate, early-stage ...
Physician's Weekly13d
Impact of Placebo on Muscle Strength and Function in Inclusion Body Myositis Trials
The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...
Yahoo Finance25d
Inclusion Body Myositis Pipeline Market Landscape Report 2025 Featuring Abcuro, Regeneron Pharmaceuticals, and Vandria
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Inclusion Body Myositis - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers in-depth insights ...
Yahoo Finance25d
Inclusion Body Myositis Pipeline Market Landscape Report 2025 Featuring Abcuro, Regeneron Pharmaceuticals, and Vandria
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Inclusion Body Myositis - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers in-depth insights into ...
BioWorld14d
New in vitro model of inclusion body myositis based on human iPSC-myotubes
Inclusion body myositis (IBM) is an inflammatory myopathy causing proximal and distal muscle weakness. IBM’s cause remains ...
Hosted on MSN26d
Abcuro secures $200m as it eyes approval for rare muscle disease drug
US-based biotech Abcuro has raised $200m to advance the development of its monoclonal antibody ulviprubart in the rare muscle disease called inclusion body myositis (IBM). The funding round, led ...